These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7511068)

  • 1. Evaluation of the therapeutic effect of TAE on primary liver cancer.
    Yamada T; Makita F; Takehara K; Saitou S; Satou K; Endou K; Shimoda R; Matsuzaki Y; Matsumoto T; Yuasa K
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S55-9. PubMed ID: 7511068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
    Okusaka T; Okada S; Ueno H; Ikeda M; Yoshimori M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Iwata R; Furukawa H; Moriyama N; Sakamoto M; Hirohashi S
    Oncology; 2000 May; 58(4):293-9. PubMed ID: 10838494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
    Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
    Aoyama K; Tsukishiro T; Okada K; Tsuchida T; Aiba N; Nambu S; Miyabayashi C; Yasuyama T; Higuchi K; Watanabe A
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S55-9. PubMed ID: 1281046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.
    Horiguchi Y; Itoh M; Takagawa H; Imai H; Kamei A; Sekoguchi B; Nagamura Y
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S60-4. PubMed ID: 1333909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S97-102. PubMed ID: 7511070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
    Higuchi T; Kikuchi M; Okazaki M
    Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Okamura J; Ogawa M; Ohashi Y; Tani M; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S1-6. PubMed ID: 1281041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
    Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.
    Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
    Yamashita F; Tanaka M; Satomura S; Tanikawa K
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):627-33. PubMed ID: 8590157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma.
    Cheung YC; Ko SF; Ng SH; Chan SC; Cheng YF
    World J Gastroenterol; 2005 May; 11(18):2792-5. PubMed ID: 15884125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization].
    Harao M; Kotake K; Kojima K; Jindou O; Ishihara M; Matsui T; Hishinuma S; Yamamoto T; Tsukioka T; Igarashi S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2366-9. PubMed ID: 12484076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.